Molly Stapleton

821 total citations
19 papers, 600 citations indexed

About

Molly Stapleton is a scholar working on Physiology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Molly Stapleton has authored 19 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 6 papers in Epidemiology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Molly Stapleton's work include Lysosomal Storage Disorders Research (14 papers), Trypanosoma species research and implications (5 papers) and Biomedical Research and Pathophysiology (4 papers). Molly Stapleton is often cited by papers focused on Lysosomal Storage Disorders Research (14 papers), Trypanosoma species research and implications (5 papers) and Biomedical Research and Pathophysiology (4 papers). Molly Stapleton collaborates with scholars based in United States, Japan and Brazil. Molly Stapleton's co-authors include Shunji Tomatsu, Robert W. Mason, Kazuki Sawamoto, Francyne Kubaski, Tadao Orii, Yasuyuki Suzuki, Carlos Javier Alméciga-Díaz, Kenji E. Orii, William G. Mackenzie and Hironori Kobayashi and has published in prestigious journals such as International Journal of Molecular Sciences, Drugs and Human Gene Therapy.

In The Last Decade

Molly Stapleton

19 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Molly Stapleton United States 12 407 187 153 83 82 19 600
Fabiano de Oliveira Poswar Brazil 12 273 0.7× 151 0.8× 186 1.2× 52 0.6× 56 0.7× 44 544
Motomichi Kosuga Japan 19 500 1.2× 223 1.2× 239 1.6× 179 2.2× 88 1.1× 54 839
Shari Fallet United States 12 322 0.8× 155 0.8× 389 2.5× 110 1.3× 75 0.9× 18 739
Mislen Bauer United States 10 269 0.7× 107 0.6× 143 0.9× 208 2.5× 75 0.9× 19 561
Yasutsugu Chinen Japan 15 371 0.9× 165 0.9× 269 1.8× 125 1.5× 70 0.9× 38 736
Kiyoko Hattori Japan 10 284 0.7× 110 0.6× 96 0.6× 69 0.8× 58 0.7× 13 391
C B Whitley United States 17 556 1.4× 214 1.1× 287 1.9× 209 2.5× 102 1.2× 30 970
Nouriya Al‐Sannaa Saudi Arabia 13 154 0.4× 88 0.5× 290 1.9× 99 1.2× 35 0.4× 27 611
Karelle Bénistan France 10 405 1.0× 216 1.2× 133 0.9× 169 2.0× 121 1.5× 31 599
William G. Mackenzie United States 20 843 2.1× 353 1.9× 217 1.4× 316 3.8× 167 2.0× 25 1.1k

Countries citing papers authored by Molly Stapleton

Since Specialization
Citations

This map shows the geographic impact of Molly Stapleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly Stapleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly Stapleton more than expected).

Fields of papers citing papers by Molly Stapleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly Stapleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly Stapleton. The network helps show where Molly Stapleton may publish in the future.

Co-authorship network of co-authors of Molly Stapleton

This figure shows the co-authorship network connecting the top 25 collaborators of Molly Stapleton. A scholar is included among the top collaborators of Molly Stapleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly Stapleton. Molly Stapleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sawamoto, Kazuki, et al.. (2024). Adeno-Associated Virus Gene Transfer Ameliorates Progression of Skeletal Lesions in Mucopolysaccharidosis IVA Mice. Human Gene Therapy. 35(23-24). 955–968. 1 indexed citations
2.
Sawamoto, Kazuki, Molly Stapleton, Shaukat Khan, et al.. (2022). Sex Difference Leads to Differential Gene Expression Patterns and Therapeutic Efficacy in Mucopolysaccharidosis IVA Murine Model Receiving AAV8 Gene Therapy. International Journal of Molecular Sciences. 23(20). 12693–12693. 18 indexed citations
3.
Stapleton, Molly, Francyne Kubaski, Robert W. Mason, et al.. (2020). Newborn screening for mucopolysaccharidoses: Measurement of glycosaminoglycans by LC-MS/MS. Molecular Genetics and Metabolism Reports. 22. 100563–100563. 28 indexed citations
4.
Sawamoto, Kazuki, Subha Karumuthil‐Melethil, Shaukat Khan, et al.. (2020). Liver-Targeted AAV8 Gene Therapy Ameliorates Skeletal and Cardiovascular Pathology in a Mucopolysaccharidosis IVA Murine Model. Molecular Therapy — Methods & Clinical Development. 18. 50–61. 28 indexed citations
5.
Tomatsu, Shunji, Francyne Kubaski, Molly Stapleton, et al.. (2020). Newborn screening for mucopolysaccharidoses: Measurement of glycosaminoglycans by LC-MS/MS. Molecular Genetics and Metabolism. 129(2). S153–S153. 14 indexed citations
6.
Langan, Thomas J., Molly Stapleton, Francyne Kubaski, et al.. (2020). Newborn screening of mucopolysaccharidoses: past, present, and future. Journal of Human Genetics. 65(7). 557–567. 22 indexed citations
7.
8.
Sawamoto, Kazuki, et al.. (2019). Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments. Drugs. 79(10). 1103–1134. 66 indexed citations
9.
Tomatsu, Shunji, et al.. (2019). Effect of enzyme replacement therapy on the growth of patients with Morquio syndrome type A. Molecular Genetics and Metabolism. 126(2). S144–S144. 1 indexed citations
10.
Khan, Shaukat, Molly Stapleton, Jianmin Wang, et al.. (2019). Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future. Biology of Blood and Marrow Transplantation. 25(7). e226–e246. 136 indexed citations
11.
Stapleton, Molly, Robert W. Mason, William G. Mackenzie, et al.. (2019). Effect of enzyme replacement therapy on the growth of patients with Morquio A. Journal of Human Genetics. 64(7). 625–635. 42 indexed citations
12.
Orii, Kenji E., Shunji Tomatsu, Molly Stapleton, et al.. (2019). Safety Study of Sodium Pentosan Polysulfate for Adult Patients with Mucopolysaccharidosis Type II. Diagnostics. 9(4). 226–226. 10 indexed citations
13.
Tomatsu, Shunji, Molly Stapleton, & Robert W. Mason. (2019). Newborn screening for mucopolysaccharidoses by GAG assay with tandem mass spectrometry. Molecular Genetics and Metabolism. 126(2). S145–S145. 1 indexed citations
14.
Stapleton, Molly, et al.. (2018). Clinical presentation and diagnosis of mucopolysaccharidoses. Molecular Genetics and Metabolism. 125(1-2). 4–17. 57 indexed citations
15.
Stapleton, Molly, Kazuki Sawamoto, Francyne Kubaski, et al.. (2018). Critical review of current MPS guidelines and management. Molecular Genetics and Metabolism. 126(3). 238–245. 26 indexed citations
16.
Stapleton, Molly, Francyne Kubaski, Robert W. Mason, et al.. (2017). Presentation and treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome). Expert Opinion on Orphan Drugs. 5(4). 295–307. 38 indexed citations
17.
Stapleton, Molly, Kazuki Sawamoto, Carlos Javier Alméciga-Díaz, et al.. (2017). Development of Bone Targeting Drugs. International Journal of Molecular Sciences. 18(7). 1345–1345. 89 indexed citations
18.
Emohare, Osa, Molly Stapleton, & Alejandro Méndez‐Zavala. (2015). A minimally invasive pericoccygeal approach to resection of a large presacral schwannoma: case report. Journal of Neurosurgery Spine. 23(1). 81–85. 11 indexed citations
19.
Stapleton, Molly, et al.. (2009). Racial and Ethnic Disparities in Intensive Autism Services in the State of Wisconsin. Minds at UW (University of Wisconsin). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabiano de Oliveira Poswar Breakdown of academic impact, for papers by Motomichi Kosuga Breakdown of academic impact, for papers by Shari Fallet Breakdown of academic impact, for papers by Mislen Bauer Breakdown of academic impact, for papers by Yasutsugu Chinen Breakdown of academic impact, for papers by Kiyoko Hattori Breakdown of academic impact, for papers by C B Whitley Breakdown of academic impact, for papers by Nouriya Al‐Sannaa Breakdown of academic impact, for papers by Karelle Bénistan Breakdown of academic impact, for papers by William G. Mackenzie
Rankless by CCL
2026